Selux Diagnostics awarded $2.8 million NIH grant for commercialization of its NGP platform
Selux Diagnostics, which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, has received a $2.8 million award from the U.S. National Institutes of Health (NIH) to help the company commercialize its NextGen ‘Phenotyping’ (NGP) platform for rapid antimicrobial susceptibility testing (AST). Having recently completed its first clinical […]